AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Tsart-M 40/50 Tablet ER

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (50mg)

Overview Tsart-M 40/50 Tablet ER

Cardio-M 40/50 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Take Cardio-M 40/50 ER with food daily at the same time for consistent blood levels. Continue as directed by your physician; don't stop even if you feel well, as hypertension is often asymptomatic. Stopping may worsen your condition. Lifestyle changes like regular exercise, weight management, and a healthy diet are also crucial. Follow your doctor's instructions closely. Potential side effects include headache, fatigue, dizziness, low blood pressure, elevated potassium, occasional orthostatic hypotension (potentially with fainting), shortness of breath, nausea, vomiting, and stomach pain. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from sitting. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor about kidney or liver issues before starting treatment. Pregnant or breastfeeding individuals should consult their doctor. Always disclose all medications, especially those for hypertension or heart conditions.

Uses of Tsart-M 40/50 Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Tsart-M 40/50 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Tsart-M 40/50 Tablet ER should be administered with a meal.

Common Side effects of Tsart-M 40/50 Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Tsart-M 40/50 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Tsart-M 40/50 Tablet ER should be administered with a meal.

How Tsart-M 40/50 Tablet ER works:

Tsart-M 40/50 Extended-Release tablets contain a dual antihypertensive formulation of telmisartan and metoprolol succinate.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Tsart-M 40/50 Tablet ER and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Tsart-M 40/50 tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Tsart-M 40/50 tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Tsart-M 40/50 tablets can reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Tsart-M 40/50 tablets are considered safe for individuals with impaired renal function. No dosage modification of Tsart-M 40/50 extended-release tablets is necessary.

LiverLiverCAUTION

Patients with hepatic impairment should use Tsart-M 40/50 ER tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Tsart-M 40/50 Tablet ER :

Should you forget a Tsart-M 40/50 Tablet ER dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed amount.

Facts to Know About Tsart-M 40/50 Tablet ER

LabelValue
Addictive None.
Medication Classification HEART

FAQs on Tsart-M 40/50 Tablet ER

Indeed, Tsart-M 40/50 Tablet ER Succinate may induce dizziness. This side effect is often experienced upon standing after prolonged periods of lying or sitting. Minimizing the risk of dizziness or fainting can be achieved by rising gradually from a recumbent or seated position.
Adopting a healthier lifestyle complements the use of Tsart-M 40/50 Tablet ER Succinate. Cigarette cessation is crucial, as smoking significantly elevates the risk of cardiovascular events such as heart attack and stroke. Weight management, including weight loss for those who are overweight or obese, is recommended. A balanced diet rich in fruits and vegetables is essential. Regular physical activity strengthens the heart and lowers the likelihood of heart attack.
Continue taking your prescribed Tsart-M 40/50 Tablet ER as directed, even if you feel healthy. Abrupt cessation of Tsart-M 40/50 Tablet ER can result in severe adverse events, including myocardial infarction and cerebrovascular accident.
Store this medication in its original, tightly sealed container or packaging, following the storage directions provided on the label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Tsart-M 40/50 Tablet ER
183
MRP 223
17% off